iiinova — where your digital self keeps evolving

Inverna Therapeutics @invernatx.com · 08/01/2025

🌟 Inverna is heading to JPM Week in SF! 🌟 Our CEO, Poul Sørensen, will share our vision for disease-modifying therapies for Huntington’s disease, powered by our RNA splicing platform. 📅 Attending too? Let’s connect to discuss partnerships and innovation! #jpm2025 #biotech #huntington #rnasplicing

🌟 Inverna is heading to San Francisco! 🌟

We’re thrilled to announce that Inverna and our CEO, Poul Sørensen, will be attending the annual JPM Week, one of the most prestigious events in the biotech and healthcare industry.

This marks an exciting opportunity for Inverna to share our vision and connect with industry leaders, innovators, and collaborators. As we continue our work in developing disease-modifying therapeutics for Huntington’s disease through our novel RNA splicing modulation platform, we are eager to engage with those who share our passion for groundbreaking science.

📅 If you’re attending the conference and would like to discuss partnerships, innovation, or simply learn more about our journey, we’d love to meet you!

Let’s build the future of biotech together.

151